LAS said it had developed an action plan to improve care for patients with sickle cell disease, including more detailed training for all frontline clinicians and improving the use of pain relief. Dr ...

Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The ...

LAS said it had developed an action plan to improve care for patients with sickle cell disease, including more detailed training for all frontline clinicians and improving the use of pain relief.

“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...

Treatment to reduce asthma-related morbidity ... at baseline and significantly increased levels during periods of sickle cell pain and ACS, [58–60] making it particularly attractive as a future ...

Findings of a research project – commissioned by London Ambulance Service (LAS) NHS Trust and carried out by the Sickle Cell Society – into sickle ... experiences included lack of appropriate pain ...